Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Medarex Inc
Medarex Inc_20100128
  

Medarex Inc patents

Recent patent applications related to Medarex Inc. Medarex Inc is listed as an Agent/Assignee. Note: Medarex Inc may have other listings under different names/spellings. We're not affiliated with Medarex Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Medarex Inc-related inventors




Date Medarex Inc patents (updated weekly) - BOOKMARK this page
09/26/13Methods of gene amplification and expression
09/26/13Interferon alpha antibodies and their uses
09/05/13Human antibodies that bind cd22 and uses thereof
09/05/13Interferon receptor 1 antibodies and their uses
08/08/13Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
08/01/13Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
07/25/13Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
06/20/13Fully human antibodies specific to cadm1
06/06/13Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1 antibodies
05/30/13Human ctla-4 antibodies and their uses
05/23/13Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
05/23/13Sequence-specific dna recombination in eukaryotic cells
05/16/13Human monoclonal antibodies to programmed death ligand 1 (pd-l1)
01/17/13Methods for enhanced protein production
10/04/12Monoclonal antibodies against cd30 lacking in fucosyl residues
09/13/12Ip-10 antibodies and their uses
08/30/12Human monoclonal antibodies to protein tyrosine kinase 7 (ptk7) and methods for using anti-ptk7 antibodies
08/16/12Human monoclonal antibodies to protein tyrosine kinase 7 (ptk7) and methods for using anti-ptk7 antibodies
07/19/12Fully human antibodies to btla
07/12/12Cation exchange chromatography (methods)
06/28/12Protein purification using hcic and ion exchange chromatography
05/10/12Human monoclonal antibodies against bacillus anthracis protective antigen
04/19/12Fully human antibodies specific to cadm1
02/23/12Hco32 and hco27 and related examples
12/08/11Interferon alpha antibodies and their uses
07/07/11Methods for the therapy of inflammatory bowel disease using a type-1 interferon antagonist
06/23/11Human antibodies that bind lymphocyte activation gene-3 (lag-3) and uses thereof
06/09/11Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
05/26/11Use of an efficacy marker for optimizing therapeutic efficacy of an anti-human pd-1 antibody on cancers
04/21/11Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
04/07/11Anti-ctla-4 antibodies with reduced blocking of binding of ctla-4 to b7 and uses thereof
02/17/11Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
02/03/11Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
02/03/11Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues
01/06/11Transgenic trasnchromosomal rodents for making human antibodies
12/23/10Human monoclonal antibodies against cd30
09/16/10Antibodies against clostridium difficile toxins and uses thereof
09/16/10Antibodies against clostridium difficile toxins and uses thereof
08/19/10Monoclonal antibodies against glypican-3
08/19/10Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors
07/29/10Protein purification
06/24/10Monoclonal antibodies against stromal derived factor-1 (sdf-1)
06/17/10Human antibodies that bind cd70 and uses thereof
06/10/10Chemical linkers and cleavable substrates and conjugates thereof
04/29/10Human antibodies that bind cxcr4 and uses thereof
04/29/10Human antibodies that bind cd19 and uses thereof
04/29/10Humanized antibodies to interferon alpha receptor-1 (ifnar-1)
04/15/10Chemical linkers and conjugates thereof
03/25/10Ip-10 antibodies and their uses
02/25/10Human ctla-4 antibodies and their uses
02/11/10Human monoclonal antibodies to protein tyrosine kinase 7 (ptk7) and methods for using anti-ptk7 antibodies
02/11/10Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
01/28/10Monoclonal antibodies against cd30 lacking in fucosyl residues
12/31/09Interferon alpha antibodies and their uses
08/27/09Therapeutic human anti-il-1r1 monoclonal antibody
08/27/09Human monoclonal antibodies to programmed death 1(pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
08/20/09Peptidyl prodrugs and linkers and stabilizers useful therefor
07/09/09Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues
07/09/09Methods of treating cancer with an antibody-drug conjugate
06/25/09Fibronectin ed-b antibodies, conjugates thereof, and methods of use
06/18/09Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
06/04/09Cd19 antibodies and their uses
05/28/09Cd10-activated prodrug compounds
05/07/09Methods of treatment using ctla-4 antibodies
04/30/09Enzyme-cleavable prodrug compounds
Patent Packs
04/30/09Stabilized chlorine dioxide and hypochlorous acid in a liquid biocide
04/23/09Protein purification using hcic and ion exchange chromatography
03/19/09Surrogate therapeutic endpoint for anti-ctla-4 based immunotherapy of disease
03/19/09Prodrugs activated by plasmin and their use in cancer chemotherapy
03/05/09Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues
02/26/09Human monoclonal antibodies to be programmed death ligand 1 (pd-l1)
01/28/10Monoclonal antibodies against cd30 lacking in fucosyl residues







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Medarex Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Medarex Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';